On May 20, 2026, the U.S. Department of Justice (DOJ) announced a settlement under the False Claims Act (FCA) with two Canada-based steel companies, Farjess Inc. and Royal Canadian Steel Inc., and their part-owner and president, Feroz Jessani, pursuant to which the companies and Jessani agreed to pay $19 million to resolve allegations that they
Healthcare & Life Sciences Private Equity Deal Tracker: Kinderhook Acquires Enhabit
Kinderhook Industries has completed its acquisition of Enhabit, according to a news release.
The deal was valued at approximately $1.1 billion.
Enhabit, founded in 2022 when it was spun off from Encompass Health Corp. and based in Dallas, is a national home health and hospice provider.
Kinderhook, founded in 2003 and based…
DoW Proposed Rule Would Impose New FOCI Disclosure and Risk Mitigation Requirements on Thousands of Defense Contractors
On May 7, 2026, the Department of War (DoW) published a proposed rule that would dramatically expand the population of defense contractors that are required to disclose beneficial ownership and foreign ownership, control, or influence (FOCI) information to the Defense Counterintelligence and Security Agency (DCSA) and to mitigate identified FOCI risks. At present, DCSA addresses FOCI only when a contractor requires access to classified information in the performance of a classified contract. The proposed rule, which amends the Defense Federal Acquisition Regulation Supplement (DFARS), would require reporting and mitigation of FOCI for DoW contractors and subcontractors that seek to perform on unclassified non-commercial contracts, as well as certain unclassified commercial contracts. The proposed rule would apply to DoW contracts and subcontracts valued in excess of $5 million and implements provisions of the National Defense Authorization Acts (NDAAs) for Fiscal Years 2020 and 2021 and DoD Instruction 5205.87.
The comment period closes on July 6, 2026. If finalized, DoW estimates that, when offerors and subcontractors are taken into account, the rule would impact over 37,000 entities, of which approximately 57% are small businesses. This alert summarizes the key provisions of the proposed rule, analyzes the practical implications for federal contractors and subcontractors, and outlines recommended steps for compliance.
Water Street Closes New Fund With $1.9 Billion
Water Street Healthcare Partners has announced the closing of its sixth private equity fund.
The fund, Water Street Healthcare Partners VI, closed with $1.9 billion in total capital commitments. The fund was oversubscribed and closed at its hard cap.
Water Street, founded in 2005 and based in Chicago, is a private equity firm focused exclusively on…
GP-Led Secondaries in Lower Middle Market, With Chris Lawrence
The secondary market has grown to roughly $220 billion as GPs and LPs scramble for liquidity in a private markets cycle stuck in a “worse distribution profile” for three and a half years. Chris Lawrence, managing partner at Labyrinth Capital Partners, joins McGuireWoods partner and host Geoff Cockrell to demystify GP-led secondaries.
Chris…
Healthcare & Life Sciences Private Equity Deal Tracker: Eir Partners Acquires QuartzBio
Eir Partners has acquired a controlling interest in QuartzBio, according to a news release.
QuartzBio, founded in 2012 and based in Frederick, Maryland, is a life science technology company that provides connected sample and biomarker intelligence for clinical-stage biopharma.
Eir, founded in 2015 and based in Miami, is a middle market private…
Going Beyond Federal Class Action Rule Kills Virginia’s Bill — For Now
On May 19, 2026, Virginia Gov. Abigail Spanberger announced that she intends to veto what would have been Virginia’s first class action statute. Virginia and Mississippi remain the only two states without a class action mechanism.
Class actions in Virginia had been discussed for some time, and with Democratic majorities in both chambers and a…
RWI in Practice: A 7-Part Series for Deal Professionals
PART 1: Representations & Warranties Insurance in Today’s Deal Market: Why It Matters More Than Ever
Introduction
Representations and warranties insurance (“RWI”) has rapidly evolved from a niche product used in select transactions to a near-standard feature in middle-market private equity deals. What was once viewed as an optional risk-transfer tool is now often a…
New Executive Order Mandates Shift to Fixed-Price Contracting, Requires Review of Largest Cost-Reimbursement Contracts
On April 30, 2026, President Trump signed an Executive Order titled “Promoting Efficiency, Accountability, and Performance in Federal Contracting” (the “Order”), directing executive branch agencies to default to fixed-price contracts and contracts that tie contractor profit to performance-based metrics in federal procurement. The Order also requires agencies to review and, to the maximum extent practicable, modify, restructure, or renegotiate their largest non-fixed-price contracts. For context, a companion White House Fact Sheet states that in Fiscal Year 2024, approximately $120 billion was obligated on cost-reimbursement consulting contracts, underscoring the scale of the shift the Order contemplates.
This alert summarizes the key provisions of the Order, analyzes its practical implications for federal contractors and subcontractors, and outlines recommended steps for compliance.
Healthcare & Life Sciences Private Equity Deal Tracker: Brightstar Invests in Simon Eye
Brightstar Capital Partners has announced an investment in Simon Eye Holdings.
Simon Eye, founded in 1987 and based in Wilmington, Delaware, is an integrated vision care platform providing optometry, optical and ophthalmology services across the Mid-Atlantic region.
Brightstar, founded in 2015 and with headquarters in New York and West Palm Beach, Florida, is…